Delphi Consensus Excessive Daytime Sleepiness in OSA

NCT05055271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-10-10

No results posted yet for this study

Summary

The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joerg Steier, PhD · King's College London (KCL), UK

  • Atul Malhotra, MD · University of California San Diego (UCSD), USA

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-09-12
Completion
2022-09-12

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05055271 on ClinicalTrials.gov